NEW YORK (GenomeWeb News) — Agilent Technologies has joined the BioIT Alliance, the company reported yesterday.
Agilent will participate in the Alliance's latest application, called the Biomarkers Project, by focusing on problematic biomedical bottlenecks. The Biomarkers Project addresses complexity in the process of identifying and validating biomarkers.
The BioIT Alliance is a diverse group of IT and biotech companies working with Microsoft to advance biomedical information technology. It deals with issues such as data-capture and data-integration challenges.
Software company QL2 joined the Alliance yesterday.